Rei Sakamoto / Shaperon CEO

規制業務・コンプライアンス用のAIの実行・統制基盤を提供しています

[Rei Sakamoto / Shaperon CEO @rskmt05]

次は肺ペストか。薬剤耐性菌の可能性大あるなあ。飛沫か齧歯類からだから、試験管を落として割るだけでは感染しないと思うんだけどなあ。

[Rei Sakamoto / Shaperon CEO @rskmt05]

rt。ケイリッドで発狂の末、Twitter買収してた（？）イーロンマスクは、結構オーソドックスな技魔ビルドでガチイン愛好。道中は装備軽くして軽/中ロリしてたみたいだし、超オーソドックス。ゲームではイーロンマスク特有みたいな感じではないよなあってのを思い出した

https://t.co/wcfiHSrmMD

[すないぬ @SunainuS]

Twitter買収する時にエルデンリングしてるイーロン・マスクも面白いんだけど、よりによってケイリッドで草

絶対に心緩まらないだろ

[Rei Sakamoto / Shaperon CEO @rskmt05]

ヨドバシカメラのTシャツのせいで、話が一ミリも入ってこない

[a16z @a16z]

Steven Sinofsky on why Jev fixes his oldest complaint about AI: natural language was never an efficient interface.

"Ask yourself how many people are really, really good at asking questions. Less than half the people can ask a good question in a meeting."

"And then how often do you look at the answer and get really frustrated before it's finished, but you have to pay all this money to watch the seven paragraphs come out...?"

"My favorite is the output of it is designed for probabilistic programming."

"Instead of saying, 'Is this a customer service question? Then route to customer service, otherwise route to general help desk,' it's, 'This is 80% customer service.' That's exactly simulation."

"There's 50 years of computer science research in literally probabilistic if statements. Suddenly the coolest place to be in computer science is gonna be probabilistic programming, which was all of computer science in the 1960s and '70s."

"This is not all new. It's gonna be very interesting to dust off all of that work, because it's exactly what's going on. An if statement now is if X percent, not if always."

"The way that Jev works is it's a custom programming language almost, which is: here's the prompt, come back with a percentage. And then you put that in the if statement."

@stevesi

[Rei Sakamoto / Shaperon CEO @rskmt05]

grok4.7からは、4.5の良さがほぼなくなってしまったように感じる

[Rei Sakamoto / Shaperon CEO @rskmt05]

Jevについては、追加学習なしで、自然言語で分類基準を指定できる汎用分類器がAPIで提供されているというのが一番のポイントかな。APIにすると何かが起きる典型例だと思う

[Rei Sakamoto / Shaperon CEO @rskmt05]

Astraは精度が高すぎるが故に、反証する余地が少ないから、却ってこちらの思考が進まない感覚がある

[Rei Sakamoto / Shaperon CEO @rskmt05]

ARC-AGI3は飛躍的成長に見えるけど、solとの対比はapple to appleじゃないから不誠実では。Standard harnessでは62.7%で、それでもsolの7.8%やopusの30.2%から見て飛躍的改善なのに勿体ない。Adapterの数値出されても...専用ハーネスなら100%は他でも事例あるし。

[OpenAI @OpenAI]

GPT-6 Astra is state-of-the-art on FrontierMath Tier 4, ARC-AGI 3, and TerminalBench-4.0.

GPT‑6 Astra is also a major advance for scientific discovery, with state-of-the-art performance on Terminal-Bench Science 0.1 and HealthBench Pro.

[Rei Sakamoto / Shaperon CEO @rskmt05]

https://t.co/PtmkVcr5AX

[Rei Sakamoto / Shaperon CEO @rskmt05]

ライフサイエンス業界向けに講演会やマーケティング資材の規制・ガイドライン対応をチェックするAIプロダクト「Shaperon Review」をリリースしました。

制作関係者と審査部門間の手戻り工数の削減や判断の標準化等が可能です。

今後、アルゴリズムを自動改善する仕組みも追加していきます

[Rei Sakamoto / Shaperon CEO @rskmt05]

スピードスケートっぽい走法だな

[Eren Chen @ErenChenAI]

Slow-motion look at the 400m champion’s running form at the World Humanoid Robot Games.

[Rei Sakamoto / Shaperon CEO @rskmt05]

日常使いのメインが完全にgrok4.5で、たまにsol

[Rei Sakamoto / Shaperon CEO @rskmt05]

今のところ、印象的なのはGrok4.5で続いてGPT-Live

[Rei Sakamoto / Shaperon CEO @rskmt05]

ブラジルというよりもアンチェロッティでは、これは。

[Rei Sakamoto / Shaperon CEO @rskmt05]

BrazilとJapanのイロレーティングが約100差なので、日本の勝率は36%ぐらいですね

https://t.co/SEsicFADKy

[Anthropic @AnthropicAI]

The US government, citing national security authorities, has issued an export control directive to suspend all access to Fable 5 and Mythos 5 by any foreign national, whether inside or outside the United States, including foreign national Anthropic employees.

The net effect of this order is that we must abruptly disable Fable 5 and Mythos 5 for all our customers to ensure compliance.

Access to all other Claude models is not affected.

We apologize for this disruption to our customers. We believe this is a misunderstanding and are working to restore access as soon as possible.

Read our full statement: https://t.co/bwn0sximKZ

[Rei Sakamoto / Shaperon CEO @rskmt05]

大炎上したからか、fableから切り替えた時に通知が出るようになりましたね。なんでこれで出るの？っていうレベルの話だったので、偽陽性すごそう

[Rei Sakamoto / Shaperon CEO @rskmt05]

イマチニブ以来のスタンディングオベーション？

[NEJM @NEJM]

Presented at #ASCO26:

Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq

@ASCO

[Maurizio Scaltriti @ScaltritiLab]

In 20 anni di congressi ho assistito a due standing ovation. La prima per un farmaco che ho contribuito a sviluppare. La seconda adesso.